Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
CardioDx raises $58 million for heart test marketing. OmniGuide gets $35 million for surgical laser products. More financings.
You may also be interested in...
News In Brief
CardioNet buys CardioCore Lab. HeartWare gears for HVAD rollout. Zimmer prevails in Genzyme patent case. CardioDx gains Corus CAD heart test Medicare coverage. More news briefs.
New Products In Brief
The latest product approvals and launches in cardiology, orthopedics, diagnostics and more.
CardioDx Launches Gene Test For Obstructive Coronary Disease
CardioDx is gradually rolling out its Corus CAD gene expression test, which quantifies the likelihood of obstructive coronary artery disease in patients with stable chest pain and no previous history of cardiac disease